Relvar Ellipta is a once-daily dual combination treatment comprising fluticasone furoate, an inhaled corticosteroid and vilanterol, a long-acting beta2-agonist, in a single inhaler, the Ellipta.

Mylan has become the first company to launch a generic version of GlaxoSmithKline's (GSK) big-selling respiratory drug Seretide in the UK. Seretide (salmeterol xinafoate/fluticasone propionate ...

Recently, visible light communication (VLC) has gradually become a research hotspot in indoor environments because its advantages of illumination and relative high positioning accuracy. But ...

In order to solve the problem of low road traffic efficiency of intelligent transportation, especially when multiple vehicles simultaneously optimize and cooperate with multiple destinations, it is ...